The Chinese University of Hong Kong announced today, Thursday, that its scientists have developed a drug to treat nasopharyngeal cancer, which may enhance the self-destruction of cancer cells. The university indicated in a statement that "nasopharyngeal cancer is a type of cancer closely associated with Epstein-Barr virus infection," noting that "the university's Faculty of Medicine has derived findings highlighting the potential to invent and develop an 'mRNA' drug for treating nasopharyngeal cancer," explaining that "this drug is capable of eliminating cancer cells."
University scientists confirmed that, in collaboration with the Jackson Laboratory in the United States, they developed the "mRNA" drug referred to as the "suicidal mechanism" to destroy cancer cells in the nasopharynx. The university concluded in its statement that the drug has been tested on mice and shown "promising results," adding that it could be used to treat other types of cancers associated with the Epstein-Barr virus.
